Usa Financial Portformulas Corp Biomarin Pharmaceutical Inc Transaction History

Usa Financial Portformulas Corp

  • $641 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 24, 2022
BUY
$82.16 - $96.94 $274,085 - $323,391
3,336 New
3,336 $283,000
Q3 2020

Oct 09, 2020
SELL
$71.87 - $131.03 $1.87 Million - $3.42 Million
-26,075 Closed
0 $0
Q2 2020

Aug 11, 2020
BUY
$79.55 - $124.22 $2.07 Million - $3.24 Million
26,075 New
26,075 $3.22 Million

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.5B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Usa Financial Portformulas Corp Portfolio

Follow Usa Financial Portformulas Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

News

Stay updated on Usa Financial Portformulas Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email